Replacement Therapy with a Purified Protein C Concentrate during Initiation of Oral Anticoagulation in Severe Protein C Congenital Deficiency

Summary

The case of an adult patient with moderately severe protein C deficiency (antigen 16%, activity 12%) is reported. Both parents had protein C levels compatible with heterozygous deficiency. Unlike other reported cases of severe protein C deficiency in adults, the onset of thrombotic symptoms occurred at 1 month of age; however, a symptom-free period until age 17 followed. Replacement therapy with a monoclonal antibody purified protein C concentrate was carried out during the initiation of oral anticoagulation after a course of i.v. heparin for deep vein thrombosis. The administration of the concentrate allowed maintenance of protein C above 50% until a stable therapeutic anticoagulation level could be obtained. This was reached within a short time, thus allowing safe administration of a loading dose of warfarin. We conclude that this approach to the prevention of skin necrosis seems more rapid and safer than previous schedules of oral anticoagulation in protein C-deficient patients.

• References

• 1 Clouse LH, Comp PC. The regulation of haemostasis: the protein C system. N Engl J Med 1986; 314: 1298-1304
• 2 Griffin JH, Evatt B, Zimmerman TS, Kleiss AJ, Wideman C. Deficiency of protein C in congenital thrombotic disease. J Clin Invest 1981; 68: 1370-1373
• 3 Broekmans AW, Conard J. Hereditary protein C deficiency. In: Protein C and Related Proteins. Bertina RM. (ed) Churchill Livingstone; Edinburgh: 1988: 160-181
• 4 Marlar RA, Mastovich S. Hereditary protein C deficiency: a review of the genetics, clinical presentation, diagnosis and treatment. Blood Coagul Fibrinol 1990; 1: 319-330
• 5 Miletich J, Sherman L, Broze Jr. G. Absence of thrombosis in subjects with heterozygous hereditary protein C deficiency. N Engl J Med 1987; 317: 991-996
• 6 Tripodi A, Franchi F, Krachmalnicoff A, Mannucci PM. Asymptomatic homozygous protein C deficiency. Acta Haematol 1990; 83: 152-155
• 7 Estellés A, Garcia-Plaza I, Dasí A, Aznar J, Duart M, Sanz G, Pérez-Requejo JL, Espana F, Jimenez C, Abeledo G. Severe inherited “homozygous” protein C deficiency in a newborn infant. Thromb Haemostas 1984; 52: 53-56
• 8 Seligsohn U, Berger A, Abend M, Rubin L, Attias D, Zivelin A, Rapaport SI. Homozygous protein C deficiency manifested by massive venous thrombosis in the newborn. N Engl J Med 1984; 310: 559-562
• 9 Marciniak E, Wilson HD, Marlar RA. Neonatal purpura fulminans: a genetic disorder related to the absence of protein C in blood. Blood 1985; 65: 15-20
• 10 Marlar RA, Montgomery R, Broekmans AW. Report on the diagnosis and treatment of homozygous protein C deficiency of the ICTHSubcommittee on Protein C and Protein S. Thromb Haemostas 1989; 61: 529-531
• 11 Samama M, Horellou MH, Soria J, Conard J, Nicolas G. Successful progressive anticoagulation in a severe protein C deficiency and previous skin necrosis at the initiation of oral anticoagulant treatment. Thromb Haemostas 1984; 51: 132-133
• 12 Grundy CB, Melissari E, Lindo V, Scully ME, Kakkar VV, Cooper DN. Late-onset homozygous protein C deficiency. Lancet 1991; i: 575-576
• 13 Conard J, Horellou MH, Van Dreden P, Samama M, Reitsma PH, Poort S, Bertina RM. Homozygous protein C deficiency with late onset and recurrent coumarin-induced skin necrosis. Lancet 1992; i: 743-744
• 14 Broekmans AW, Bertina RM, Loeliger EA, Hofmann V, Klingemann HG. Protein C and the development of skin necrosis during anticoagulant therapy. Thromb Haemostas 1983; 49: 244
• 15 McGehee WG, Klotz TA, Epstein DJ, Rapaport SI. Coumarin necrosis associated with hereditary protein C deficiency. Ann Intern Med 1984; 101: 59-60
• 16 Zauber NP, Stark MW. Successful warfarin anticoagulation despite protein C deficiency and a history of warfarin necrosis. Ann Intern Med 1986; 104: 659-660
• 17 Pabinger-Fasching I, Lechner K, Niessner H, Korninger C, Kyrle PA. Protein C and coagulation factor level during the initial phase of oral anticoagulant therapy (low dose regimen) in a patient with heterozygous protein C deficiency. Thromb Res 1987; 47: 705-708
• 18 Teofili L, De Stefano V, Leone G, Micalizzi P, Iovino MS, Alfano G, Bizzi B. Hematological causes of venous thrombosis in young people: high incidence of myeloproliferative disorder as underlying disease in patients with splanchnic venous thrombosis. Thromb Haemostas 1992; 67: 297-301
• 19 Dreyfus M, Magny JF, Bridey F, Schwarz HP, Planché C, Dehan M, Tchernia G. Treatment of homozygous protein C deficiency and neonatal purpura fulminans with a purified protein C concentrate. N Engl J Med 1991; 325: 1565-1568
• 20 Vinazzer H, Pangraz U, Protein C. Comparison of different assays in normal and abnormal plasma samples. Thromb Res 1987; 46: 1-8
• 21 Franchi F, Tripodi A, Valsecchi C, Mannucci PM. Functional assays of protein C: comparison of two snake-venom assays with two thrombin assays. Thromb Haemostas 1988; 60: 145-147
• 22 Majer RV, Chisholm M, Hickton MC. Replacement therapy for protein C deticiency using fresh frozen plasma. Br J Haematol 1989; 72: 475